| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |